Giddings v. Bristol-Myers Squibb Co., CIV.A.AW-97-101.

Decision Date29 March 2002
Docket NumberNo. CIV.A.AW-97-101.,CIV.A.AW-97-101.
Citation192 F.Supp.2d 421
PartiesMark GIDDINGS, Personal Representative for the Estate of Pauline Rodman, Deceased, Plaintiff, v. BRISTOL-MYERS SQUIBB CO. et al, Defendant.
CourtU.S. District Court — District of Maryland

Douglas R. Thomas, Thomas, Pearlstein and Essex, Beltsville, MD, Leslie D. Silverman, Law Office, Beltsville, MD, for plaintiff.

Richard Alan Dean, Arter and Hadden LLP, Washington, DC, for defendants.

MEMORANDUM OPINION

WILLIAMS, District Judge.

Plaintiff brings this products liability case on behalf of his deceased mother, Mrs. Pauline Rodman, alleging defects in certain breast implants manufactured by Defendants, Bristol-Myers Squibb Co. ("Bristol-Myers"), Medical Engineering Corp. ("MEC"), and MEC Subsidiary Corp. (formerly known as "Surgitek"). On May 3, 2001, the Court granted Defendants' Motion for partial summary judgment relating to all claims of wrongful death and systemic injury. Pending before the Court is Defendants' Motion for Summary Judgment as to the remaining claims for local inflammation of breast tissue. Alternatively, Defendants move to exclude Plaintiff's two experts, who are preparing to testify on the issues of product defect and causation.

The parties have fully briefed the Motion. No hearing is deemed necessary. See Local Rule 105.6. Upon consideration of the arguments made in support of, and opposition to, the respective motion, the Court makes the following determinations.

I. FACTUAL BACKGROUND

In 1979, Dr. Teimourian, Mrs. Rodman's doctor, surgically implanted an artificial breast, manufactured by MEC, in the right-hand portion of Mrs. Rodman's chest. The breast implant was the result of reconstruction surgery following a mastectomy of her right breast due to cancer. Mrs. Rodman never had an implant in her left breast. In 1992, following complaints of discomfort, the same doctor partially removed the artificial breast. At that time, the doctor found a rupture in the implant. Because of Mrs. Rodman's health, the doctor completed only a partial removal of the implant.

Mrs. Rodman died in 1996. During the autopsy, Dr. King of the Maryland Medical Examiner's Office found another breast implant (hereinafter "second breast implant") in Mrs. Rodman's right breast. The second breast implant was not ruptured1 and its manufacturer remains unknown. Moreover, the parties do not know how, when or who placed the second breast implant in Mrs. Rodman.2 Dr. King took a biopsy of the surrounding tissue and noted an inflammation in the immediate area of the breast capsule.

Initially brought in 1997, this case boils down to whether the MEC breast implant or the second breast implant, if either, was defective and caused the alleged injury. Plaintiff argues that the MEC breast implant caused the inflammation and injury. Defendants argue that their implant was not defective and that the second breast implant caused the alleged injury. Defendants move for summary judgment or, in the alternative, to preclude Plaintiff's experts from testifying that the MEC breast implant was defective or caused the alleged injury.

II. DISCUSSION
A. Motion for Summary Judgment

In reviewing a motion for summary judgment, the court must review the facts in the light most favorable to the nonmoving party. Anderson v. Liberty Lobby, 477 U.S. 242, 255, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). The court must "draw all justifiable inferences in favor of the nonmoving party, including questions of credibility and of the weight to be accorded to particular evidence." Masson v. New Yorker Magazine, 501 U.S. 496, 520, 111 S.Ct. 2419, 115 L.Ed.2d 447 (1991) (citations omitted). Rule 56(c) of the Federal Rules of Civil Procedure provides that the entry of summary judgment is proper, "after adequate time for discovery and upon motion, against a party who fails to make a showing sufficient to establish the existence of an element essential to that party's case, and on which that party will bear the burden of proof at trial." Cray Communications, Inc. v. Novatel Computer Systems, Inc., 33 F.3d 390, 393 (4th Cir. 1994); see also LeBlanc v. Cahill, 153 F.3d 134 (4th Cir.1998).

In Maryland, "[r]egardless of the recovery theory, the plaintiff in product liability litigation must satisfy three basics from an evidentiary standpoint: 1) the existence of a defect; 2) the attribution of the defect to the seller; and 3) a causal relation between the defect and the injury." Jensen v. American Motors, Corp., 50 Md.App. 226, 234, 437 A.2d 242, 247 (Md.Spec.App.1981) quoted in Foster v. American Home Products Corp., 29 F.3d 165, 168 (4th Cir.1994) (finding that the same causation requirement applies to actions for negligent misrepresentation of a product). "[P]roof of defect and causation is also required to support [Plaintiff's] breach of warranty claim." Miskin v. Baxter Healthcare Corp., 107 F.Supp.2d 669, 672 (D.Md.1999), aff'd, 213 F.3d 632, 2000 WL 517518 (4th Cir.2000) (unpublished opinion). At the summary judgment stage, failure to produce evidence of an essential element may be fatal to a Plaintiff's case. See Drewitt v. Pratt, 999 F.2d 774, 778-79 (4th Cir.1993) (recognizing that it is an affirmative obligation of the trial judge to prevent factually unsupported claims and defenses from going to trial) (quoting Felty v. Graves-Humphreys Co., 818 F.2d 1126, 1128 (4th Cir.1987)).

Regarding causation, Plaintiff has the burden of showing generally that the MEC breast implants could cause the injury and specifically that breast implants were the cause-in-fact of the injury. See Lee v. Baxter Healthcare Corp., 721 F.Supp. 89, 95 (D.Md.1989), (citing Phipps v. General Motors, 278 Md. 337, 363 A.2d 955 (1976)); see also Owens-Illinois, Inc. v. Armstrong, 326 Md. 107, 117, 604 A.2d 47 (1992). To satisfy this burden "[e]xpert testimony is usually necessary since the evidence relating to causation involves technical medical questions beyond the common knowledge of laypersons, and the interaction of a breast prosthesis with the human body raises technical questions requiring expert testimony." Miskin v. Baxter Healthcare Corp. 107 F.Supp.2d 669, 672 (D.Md.1999). Nevertheless, like other evidence, where a party offers irrelevant or unreliable expert testimony to satisfy an element of the offense, the trial Court may exclude the expert testimony from its summary judgment consideration. Cavallo v. Star Enter., 100 F.3d 1150, 1159 (4th Cir.1996).

Citing Miller v. Bristol-Myers Squibb, 121 F.Supp.2d 831 (D.Md.2000), Defendants argue that summary judgment is appropriate because, as a matter of law, they cannot be held responsible for an injury allegedly caused by an implant, where there is no evidence they made the implant. In Miller this Court observed that "[u]nder Maryland law, the inability of a plaintiff to establish that a defendant actually manufactured her breast implants creates a material deficiency in her prima facie case—the element of causation." Miller v. Bristol-Myers Squibb, 121 F.Supp.2d 831, 837 (D.Md.2000). There, this Court granted summary judgment to the defendant, a manufacturer of breast implants, because the plaintiff could not establish which defendant manufactured her implant, and therefore, plaintiff could not establish who caused her alleged injury. Id.

While not directly analogous, the Court agrees that Miller is instructive with regard to what courts must do when a plaintiff fails to produce evidence necessary to develop a prima facie case. Here, Defendants do not dispute that they manufactured the breast implant, that the breast implant was surgically implanted in Mrs. Rodman's body, and that the breast implant ruptured. Defendants also do not dispute that Plaintiff can produce at least some evidence of injury. Defendants dispute product defect and causation, arguing that it was the second breast implant, if either, that caused the injury and that Plaintiff has produced insufficient evidence, as a matter of law, to survive summary judgment. Defendants argue that the absence of evidence of a defect creates material deficiencies in plaintiff's prima facie case. Because Plaintiff proffers expert testimony to satisfy its burden of proof as to product defect and causation, and without such evidence Plaintiff lacks evidence sufficient to meet its burden at trial, the Court finds it necessary in its summary judgment analysis to turn directly to Defendants' alternative Motion to preclude Plaintiff's two experts. For the reasons discussed below, the Court finds material deficiencies in Plaintiff's prima facie case and, therefore, grants Defendants' Motion for Summary Judgment.

B. Motion to Preclude Experts from Testifying

Defendants move to bar the testimony of Plaintiff's two experts on the local injury claim. Plaintiff first expert, Dr. Pierre Blais, a chemist, will speak to the alleged product defect, namely:

"the appropriateness of the materials defendants chose to incorporate into their products, the compatibility of those materials with each other and with the biological tissue, and the likelihood of failure after a certain period of time."

Plaintiff's Opp. at 14. Plaintiff's second expert, Dr. Andrew Tegeris, a pathologist who reviewed the pathology slide created during the 1996 autopsy, will speak to the alleged causal link between the defect and the injury. He will testify that the defect caused silicone gel to be released into Mrs. Rodman's chest, causing chronic inflammation of her breast tissue and pain. Dr. Tegeris' testimony rests on the foundation of Dr. Blais' testimony. If either is barred, Plaintiff's remaining local injury claim will fail because one's testimony is necessary to establish a product defect, and the other is necessary to show causation.

An expert may state an opinion or conclusion if the subject matter is appropriate, the witness is qualified, the witness possesses a reasonable probability regarding the opinion, the...

To continue reading

Request your trial
12 cases
  • SMD Software, Inc. v. Emove, Inc.
    • United States
    • U.S. District Court — Eastern District of North Carolina
    • March 29, 2013
    ...at 141–42, 119 S.Ct. 1167). One factor pertinent to reliability is the proposed expert's qualifications. See Giddings v. Bristol–Myers Squibb Co., 192 F.Supp.2d 421, 425 (D.Md.2002). A witness may qualify to render expert opinions in any one of the five ways listed in Rule 702: knowledge, s......
  • SAS Inst., Inc. v. World Programming Ltd., 5:10–CV–25–FL.
    • United States
    • U.S. District Court — Eastern District of North Carolina
    • August 12, 2015
    ...141–42, 119 S.Ct. 1167 ). One factor pertinent to reliability is the proposed expert's qualifications. See Giddings v. Bristol–Myers Squibb Co., 192 F.Supp.2d 421, 425 (D.Md.2002). A witness may qualify to render expert opinions in any one of the five ways listed in Rule 702 : knowledge, sk......
  • United States v. $307,970.00 in U.S. Currency
    • United States
    • U.S. District Court — Eastern District of North Carolina
    • May 20, 2019
    ...quotations omitted). One factor pertinent to reliability is the proposed expert's qualifications. See Giddings v. Bristol-Myers Squibb Co., 192 F.Supp.2d 421, 425 (D. Md. 2002). A witness may qualify to render expert opinions in any one of the five ways listed in Rule 702: knowledge, skill,......
  • DeRosier v. USPlabs, LLC, Civil No. CCB-10-2559
    • United States
    • U.S. District Court — District of Maryland
    • November 17, 2011
    ...the Court's gate keeping function is to ensure that the expert testimony is more than mere speculation," Giddings v. Bristol-Myers Squibb Co., 192 F. Supp. 2d 421, 425 (D. Md. 2002), and this court cannot find that Mr. Merriweather's testimony, though sincere, rises above the level of conje......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT